Table IV.
Dependent variable | R2 | Analysis of variance | Model | B | β | t-value | P-value |
---|---|---|---|---|---|---|---|
Pain intensity | 0.28 | F=9.17, P<0.01 | Constant | 0.47 | – | 0.61 | 0.54 |
over the last month | Neuropathy score | 0.08 | 0.24 | 2.43 | 0.02 | ||
Duration of DM | 0.08 | 0.11 | 1.30 | 0.20 | |||
Number of painful sites | 0.22 | 0.28 | 2.90 | <0.01 | |||
Sex | 0.38 | 0.08 | 0.95 | 0.34 | |||
Statin therapy | −0.31 | −0.07 | −0.80 | 0.43 | |||
Number of | 0.36 | F=13.27, P<0.01 | Constant | 2.69 | – | 2.72 | 0.01 |
painful sites | Neuropathy score | 0.24 | 0.56 | 6.87 | <0.01 | ||
Duration of DM | 0.07 | 0.08 | 0.97 | 0.33 | |||
Anxiety score | 0.03 | 0.04 | 0.56 | 0.58 | |||
Sex | −0.04 | −0.01 | −0.09 | 0.93 | |||
Statin therapy | −0.47 | −0.08 | −1.00 | 0.32 |
P-values were determined by multiple linear regression analysis. Statistically significant values (P<0.05) are emboldened. R2, squared coefficient of determination; B, unstandardized coefficient; β, standardized coefficient; F, F-statistic; DM, diabetes mellitus.